Title : Pemetrexed (Alimta): a promising new agent for the treatment of breast cancer.

Pub. Date : 2003 Apr

PMID : 12722017






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Pemetrexed (Alimta; Eli Lilly and Company, Indianapolis, IN) is a new antifolate drug with activity at multiple points in folate metabolism, including thymidylate synthase, dihydrofolate reductase, and glycinamide ribonucleotide formyltransferase. Pemetrexed dihydrofolate reductase Homo sapiens